Molecular Data Gross Profit

Molecular Data (MKD) currently reports a gross profit of $100M as of December 2020. That is below the Industrials sector average of $120B. Use the charts on this page to explore Molecular Data's gross profit history and peer comparisons.

Molecular Data's gross profit of $100M is lower than the Industrials sector average of $120B. That is roughly 99.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Molecular Data reported $100M in gross profit as of December 2020. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is $120B. From there, open related valuation or income-statement pages for Molecular Data, and consider following MKD for alerts when major investors trade the stock.

Molecular Data is classified in the Industrials sector. On gross profit, it currently shows $100M versus a sector average near $120B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing MKD with unrelated industries.